Literature DB >> 25408802

Assessing radiation exposure during endoscopic-guided percutaneous nephrolithotomy.

Andrea G Lantz1, Padraic O'Malley2, Michael Ordon2, Jason Y Lee2.   

Abstract

INTRODUCTION: Percutaneous nephrolithotomy (PCNL) may be associated with significant ionizing radiation exposure for patients and operating room staff. Endoscopic-guided PCNL (ePCNL) is a technique that may be associated with less radiation exposure. This study examines ePCNL-related radiation exposure (fluoroscopy time, effective dose) and investigates variables that may predict increased exposure.
METHODS: A retrospective review of all consecutive ePCNLs performed at our institution, by a single surgeon, was conducted between November 2011 and November 2013. Patient demographics, stone characteristics and perioperative details were recorded, including radiation exposure. Pearson and Spearman correlation were used to assess variables correlated with radiation exposure.
RESULTS: In total, 55 ePCNL cases were included in the study. The mean age was 60 ± 15 years, mean body mass index (BMI) 30.0 ± 6.4 kg/m(2) and mean stone size 3.2 × 2.1 cm. Seven cases (13%) involved complete staghorn stones, and 69% involved supracostal punctures. The mean fluoroscopy time was 3.4 ± 2.3 minutes, mean ED 2.4 ± 1.9 mSv. The treatment success rate, assessed 1-week postoperatively, was 87.3% and 7.3% of cases required ancillary procedures. The overall complication rate was 29%, but only 3 cases (5.5%) were Clavien ≥3. Longer fluoroscopy time correlated with increased stone size (p < 0.01), longer operative time (p < 0.01) and lower treatment success rates (p < 0.01); higher effective dose correlated with longer fluoroscopy time (p < 0.01) and increased skin-to-stone distance (p < 0.01). BMI did not correlate with fluoroscopy time or effective dose.
CONCLUSIONS: Outcomes of ePCNL are comparable to traditional PCNL techniques and may be associated with lower radiation exposure, particularly beneficial for patients with higher BMI.

Entities:  

Year:  2014        PMID: 25408802      PMCID: PMC4216293          DOI: 10.5489/cuaj.2037

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  28 in total

1.  Estimated radiation risks potentially associated with full-body CT screening.

Authors:  David J Brenner; Carl D Elliston
Journal:  Radiology       Date:  2004-07-23       Impact factor: 11.105

2.  Organ-specific radiation dose rates and effective dose rates during percutaneous nephrolithotomy.

Authors:  Michael E Lipkin; John G Mancini; Greta Toncheva; Agnes J Wang; Colin Anderson-Evans; W Neal Simmons; Michael N Ferrandino; Terry T Yoshizumi; Glenn M Preminger
Journal:  J Endourol       Date:  2011-09-23       Impact factor: 2.942

3.  Percutaneous pyelolithotomy. A new extraction technique.

Authors:  I Fernström; B Johansson
Journal:  Scand J Urol Nephrol       Date:  1976

Review 4.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

Review 5.  The risk of radiation exposure to assisting staff in urological procedures: a literature review.

Authors:  Tarun Jindal
Journal:  Urol Nurs       Date:  2013 May-Jun

6.  Endoscopy-guided percutaneous nephrostolithotomy: benefits of ureteroscopic access and therapy.

Authors:  Petros G Sountoulides; Oskar G Kaufmann; Michael K Louie; Shawn Beck; Nickul Jain; Adam Kaplan; Elspeth M McDougall; Ralph V Clayman
Journal:  J Endourol       Date:  2009-10       Impact factor: 2.942

7.  Influence of surgeon's experience on fluoroscopy time during endourological interventions.

Authors:  M Ritter; F Siegel; P Krombach; A Martinschek; C Weiss; A Häcker; A E Pelzer
Journal:  World J Urol       Date:  2012-08-12       Impact factor: 4.226

8.  Endoscopic-guided versus fluoroscopic-guided renal access for percutaneous nephrolithotomy: a comparative analysis.

Authors:  Wahib Isac; Emad Rizkala; Xiaobo Liu; Mark Noble; Manoj Monga
Journal:  Urology       Date:  2013-02       Impact factor: 2.649

9.  Radiation exposure in the acute and short-term management of urolithiasis at 2 academic centers.

Authors:  Michael N Ferrandino; Aditya Bagrodia; Sean A Pierre; Charles D Scales; Edward Rampersaud; Margaret S Pearle; Glenn M Preminger
Journal:  J Urol       Date:  2008-12-18       Impact factor: 7.450

10.  Cancer risk in diagnostic radiation workers in Korea from 1996&#8211;2002.

Authors:  Kyung-Hwa Choi; Mina Ha; Won Jin Lee; Seung-Sik Hwang; Meeseon Jeong; Young-Woo Jin; Hyeog Ju Kim; Kwang-Yong Lee; Jung-Eun Lee; Jong-Won Kang; Heon Kim
Journal:  Int J Environ Res Public Health       Date:  2013-01-14       Impact factor: 3.390

View more
  5 in total

1.  Ureteroscopic holmium laser-assisted retrograde nephrostomy access: a novel approach to percutaneous stone removal.

Authors:  Kamaljot S Kaler; Egor Parkhomenko; Zhamshid Okunohov; Roshan M Patel; Jaime Landman; Ralph V Clayman; Carlos A Uribe
Journal:  World J Urol       Date:  2018-02-08       Impact factor: 4.226

Review 2.  Lifetime Radiation Exposure in Patients with Recurrent Nephrolithiasis.

Authors:  Mohamed A Elkoushy; Sero Andonian
Journal:  Curr Urol Rep       Date:  2017-09-12       Impact factor: 3.092

3.  Does the presence of a percutaneous renal access influence fluoroscopy time during percutaneous nephrolithotomy?

Authors:  Yasser A Noureldin; Mohamed A Elkoushy; Sero Andonian
Journal:  Asian J Urol       Date:  2015-08-18

4.  Efficacy and safety of modified tract dilation technique using simultaneous pulling of proximal and distal ends of a guidewire for percutaneous nephrolithotomy in modified supine position.

Authors:  Jae Wook Chung; Heon Ha; Dong Jin Park; Yun Sok Ha; Jun Nyung Lee; So Young Chun; Tae Gyun Kwon; Bum Soo Kim
Journal:  Investig Clin Urol       Date:  2021-03

5.  Ultrasound Guidance for Renal Tract Access and Dilation Reduces Radiation Exposure during Percutaneous Nephrolithotomy.

Authors:  Thomas Chi; Selma Masic; Jianxing Li; Manint Usawachintachit
Journal:  Adv Urol       Date:  2016-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.